QUICK SEARCH: [advanced] Author: Keyword(s): Year: Vol: Page: This Article Full Text (PDF) Submit a response Alert me when this article is cited ... Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal ... Cited by other online articles PubMed PubMed Citation Articles by Antin, J. H. J Clin Invest, June 2001, Volume 107, Number 12, 1497-1498 Commentary Acute graft-versus-host disease: inflammation run amok? Joseph H. Antin Address correspondence to: Joseph H. Antin, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA. Phone: (617) 632-2525; Fax: (617) 632-5175; E-mail: Hematopoietic stem cell transplantation (HSCT) has substantially fulfilled its promise as a curative therapy for hematopoietic disorders and some disorders of metabolism. More recently, it has been investigated for its potential in establishing tolerance for organ transplantation. In its typical application, conditioning steps involving cytotoxic radiation or chemotherapy are administered first, after which some combination of stem cells, lymphocytes | |
|